For instance it is commonly accepted that anti-inflammatory drugs are able to block important inflammatory pathways such as NF-κB, and mitogen-activated protein kinase (MAPK; Fard et al., 2015; Arulselvan et al., 2016) and these could be explored as treatments to ameliorate cognitive decline with age. The gene discussed is WNK2; the disease is Mental deterioration.